Table 2.
Occurrence and distribution of structural changes in the pelvic LN according to age groups (* significant value indicates differences in age groups).
| Structural Change | Over All | ≤60 Years | 61–70 Years | ≥71 Years | p | |
|---|---|---|---|---|---|---|
| LN size | <10 mm | 2701 (52.2%) | 458 (49.4%) | 1358 (50.9%) | 885 (56.1%) | |
| ≥10 mm | 2472 (47.8%) | 469 (50.6%) | 1310 (49.1%) | 693 (43.9%) | 0.001 * | |
| Framework fibrosis | none | 3614 (69.9%) | 726 (78.3%) | 1836 (68.8%) | 1052(66.7%) | |
| milde | 1224 (23.7%) | 154 (16.6%) | 674 (25.3%) | 396 (25.1%) | ||
| moderate | 308 (6.0%) | 43 (4.6%) | 141(5.3%) | 124 (7.9%) | ||
| high | 27 (0.5%) | 4 (0.4%) | 17 (0.6%) | 6 (0.4%) | <0.001 * | |
| Capsular fibrosis | with | 1814 (35.1%) | 273 (29.4%) | 929 (34.8%) | 612 (38.8%) | |
| without | 3359 (64.9%) | 645 (70.6%) | 1739 (65.2%) | 966 (61.2%) | <0.001 * | |
| Calcification | with | 2376 (45.9%) | 357 (38.5%) | 1230 (46.1%) | 789 (50.0%) | |
| without | 2797 (54.1%) | 570 (61.5%) | 1438 (53.9%) | 789 (50.0%) | <0.001 * | |
| Lipomatous atrophy | ≤30% | 3464 (67.0%) | 589 (63.5%) | 1852 (69.4%) | 1023 (64.8%) | |
| 31–60% | 678 (13.1%) | 111 (12.0%) | 323 (12.1%) | 244 (15.5%) | ||
| ≥61% | 1031 (19.9%) | 227 (24.5%) | 493 (18.5%) | 311 (19.7%) | <0.001 * | |